Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Straub

Showing results (31-40 of 374) with videos related to

Pageof 38
Sort By:
Disability and Rehabilitation|December 20, 2017
Psychometric properties of the Zarit Caregiver Burden Interview administered to caregivers to patients with Duchenne muscular dystrophy: a Rasch analysisErik Landfeldt, Anna Mayhew, Volker Straub, et al.
Neuromuscular Disorders : NMD|January 14, 2026
286th ENMC international workshop: Muscle imaging: artificial intelligence, automatic segmentation and imaging data sharing in neuromuscular disease. Hoofddorp, The Netherlands, 7-9 March 2025Jodi Warman-Chardon, Volker Straub, John Vissing, et al.
Pharmacoeconomics|November 1, 2016
Economic Evaluation in Duchenne Muscular Dystrophy: Model Frameworks for Cost-Effectiveness AnalysisErik Landfeldt, Lars Alfredsson, Volker Straub, et al.
Magnetic Resonance in Medicine|November 6, 2018
Noninvasive quantification of fibrosis in skeletal and cardiac muscle in mdx mice using EP3533 enhanced magnetic resonance imagingAlexander Peter Murphy, Elizabeth Greally, Dara O'Hogain, et al.
Frontiers in Neurology|July 5, 2021
Use of EP3533-Enhanced Magnetic Resonance Imaging as a Measure of Disease Progression in Skeletal Muscle of <i>mdx</i> MiceAlexander Peter Murphy, Elizabeth Greally, Dara O'Hogain, et al.
Plos One|February 26, 2013
Beta-blockers, left and right ventricular function, and in-vivo calcium influx in muscular dystrophy cardiomyopathyAlison Blain, Elizabeth Greally, Steve Laval, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 17, 2007
From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesisLars Klinge, Steve Laval, Sharon Keers, et al.
Radiology|January 10, 2015
Improving highly accelerated fat fraction measurements for clinical trials in muscular dystrophy: origin and quantitative effect of R2* changesThomas Loughran, David M Higgins, Michelle McCallum, et al.
Neuromuscular Disorders : NMD|June 27, 2009
Immunohistochemical analysis of calpain 3: advantages and limitations in diagnosing LGMD2ARichard Charlton, Matthew Henderson, Julie Richards, et al.
Magnetic Resonance in Medicine|December 19, 2013
Investigating the quantitative fidelity of prospectively undersampled chemical shift imaging in muscular dystrophy with compressed sensing and parallel imaging reconstructionKieren G Hollingsworth, David M Higgins, Michelle McCallum, et al.
Pageof 38

Showing results (31-40 of 374) with videos related to

Sort By:
Pageof 38
Disability and Rehabilitation|December 20, 2017
Psychometric properties of the Zarit Caregiver Burden Interview administered to caregivers to patients with Duchenne muscular dystrophy: a Rasch analysisErik Landfeldt, Anna Mayhew, Volker Straub, et al.
Neuromuscular Disorders : NMD|January 14, 2026
286th ENMC international workshop: Muscle imaging: artificial intelligence, automatic segmentation and imaging data sharing in neuromuscular disease. Hoofddorp, The Netherlands, 7-9 March 2025Jodi Warman-Chardon, Volker Straub, John Vissing, et al.
Pharmacoeconomics|November 1, 2016
Economic Evaluation in Duchenne Muscular Dystrophy: Model Frameworks for Cost-Effectiveness AnalysisErik Landfeldt, Lars Alfredsson, Volker Straub, et al.
Magnetic Resonance in Medicine|November 6, 2018
Noninvasive quantification of fibrosis in skeletal and cardiac muscle in mdx mice using EP3533 enhanced magnetic resonance imagingAlexander Peter Murphy, Elizabeth Greally, Dara O'Hogain, et al.
Frontiers in Neurology|July 5, 2021
Use of EP3533-Enhanced Magnetic Resonance Imaging as a Measure of Disease Progression in Skeletal Muscle of <i>mdx</i> MiceAlexander Peter Murphy, Elizabeth Greally, Dara O'Hogain, et al.
Plos One|February 26, 2013
Beta-blockers, left and right ventricular function, and in-vivo calcium influx in muscular dystrophy cardiomyopathyAlison Blain, Elizabeth Greally, Steve Laval, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 17, 2007
From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesisLars Klinge, Steve Laval, Sharon Keers, et al.
Radiology|January 10, 2015
Improving highly accelerated fat fraction measurements for clinical trials in muscular dystrophy: origin and quantitative effect of R2* changesThomas Loughran, David M Higgins, Michelle McCallum, et al.
Neuromuscular Disorders : NMD|June 27, 2009
Immunohistochemical analysis of calpain 3: advantages and limitations in diagnosing LGMD2ARichard Charlton, Matthew Henderson, Julie Richards, et al.
Magnetic Resonance in Medicine|December 19, 2013
Investigating the quantitative fidelity of prospectively undersampled chemical shift imaging in muscular dystrophy with compressed sensing and parallel imaging reconstructionKieren G Hollingsworth, David M Higgins, Michelle McCallum, et al.
Pageof 38